Sonninen P - Search Results

1

Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence.

Hietala J, West C, Syvälahti E, Någren K, Lehikoinen P, Sonninen P, Ruotsalainen U. Hietala J, et al. Among authors: sonninen p. Psychopharmacology (Berl). 1994 Nov;116(3):285-90. doi: 10.1007/BF02245330. Psychopharmacology (Berl). 1994. PMID: 7892418 Clinical Trial.

2

Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal study.

Kaasinen V, Aalto S, NAgren K, Hietala J, Sonninen P, Rinne JO. Kaasinen V, et al. Among authors: sonninen p. J Neural Transm (Vienna). 2003 Jun;110(6):591-601. doi: 10.1007/s00702-003-0816-x. J Neural Transm (Vienna). 2003. PMID: 12768355

3

CT, MRI, and PET in a case of intractable epilepsy.

Metsähonkala L, Aärimaa T, Sonninen P, Mikola H, Ruotsalainen U, Bergman J. Metsähonkala L, et al. Among authors: sonninen p. Childs Nerv Syst. 1996 Jul;12(7):421-4. doi: 10.1007/BF00395100. Childs Nerv Syst. 1996. PMID: 8869782

4

Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E, Norrgård S, Kulmala J, Teräs M, Minn H. Nuutinen J, et al. Among authors: sonninen p. Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52. doi: 10.1016/s0360-3016(00)00604-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 10924970

5

Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.

Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, Utriainen T, Roivainen A, Kalimo H, Minn H. Utriainen M, et al. Among authors: sonninen p. J Neurooncol. 2003 May;62(3):329-38. doi: 10.1023/a:1023342516925. J Neurooncol. 2003. PMID: 12777086

6

Striatal uptake of a novel PET ligand, [18F]beta-CFT, is reduced in early Parkinson's disease.

Rinne JO, Bergman J, Ruottinen H, Haaparanta M, Eronen E, Oikonen V, Sonninen P, Solin O. Rinne JO, et al. Among authors: sonninen p. Synapse. 1999 Feb;31(2):119-24. doi: 10.1002/(SICI)1098-2396(199902)31:2<119::AID-SYN4>3.0.CO;2-O. Synapse. 1999. PMID: 10024008

7

Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study.

Jääskeläinen SK, Rinne JO, Forssell H, Tenovuo O, Kaasinen V, Sonninen P, Bergman J. Jääskeläinen SK, et al. Among authors: sonninen p. Pain. 2001 Feb 15;90(3):257-260. doi: 10.1016/S0304-3959(00)00409-7. Pain. 2001. PMID: 11207397

8

Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.

Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO. Nurmi E, et al. Among authors: sonninen p. Synapse. 2003 Jun 1;48(3):109-15. doi: 10.1002/syn.10192. Synapse. 2003. PMID: 12645035

9

Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.

Nurmi E, Bergman J, Eskola O, Solin O, Hinkka SM, Sonninen P, Rinne JO. Nurmi E, et al. Among authors: sonninen p. J Cereb Blood Flow Metab. 2000 Nov;20(11):1604-9. doi: 10.1097/00004647-200011000-00010. J Cereb Blood Flow Metab. 2000. PMID: 11083235 Clinical Trial.

10

Personality traits and brain dopaminergic function in Parkinson's disease.

Kaasinen V, Nurmi E, Bergman J, Eskola O, Solin O, Sonninen P, Rinne JO. Kaasinen V, et al. Among authors: sonninen p. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13272-7. doi: 10.1073/pnas.231313198. Epub 2001 Oct 30. Proc Natl Acad Sci U S A. 2001. PMID: 11687621 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters